Master Degree / Yüksek Lisans Tezleri

Permanent URI for this collectionhttps://hdl.handle.net/11147/3008

Browse

Search Results

Now showing 1 - 4 of 4
  • Master Thesis
    Studies Toward the Synthesis of Novel Mdm2 Inhibitor Candidates
    (Izmir Institute of Technology, 2018) Dilek, Fikrican; Çağır, Ali
    Protein protein interactions are valuable targets to discover novel anticancer agents. One of these is the p53-MDM2 interaction. In one of these interaction MDM2 protein inhibits p53 protein and may cause cancer. New drugs that inhibit this interaction are important for the treatment of cancer. One class of these anticancer agents are morpholinone derivative. In this study, it is aimed to synthesize new morpholinone derivatives. (R)-2-amino-2-(4-chlorophenyl)acetic acid was used as starting material for the synthesis. The first step was a trityl protection of amine with trityl chloride. Trityl protected amino acid was first reduced to N-Trt amino alcohol with LiAlH4 then oxidized to aldehyde by using Dess-Martin periodinane. The resulting aldehyde was reacted with 3-chlorophenylmagnesium bromide. This part of the synthesis was performed successfully. Then addition of methyl fumarate to this Grignard product was studied by a coupling reagents such as HATU. All attempts were failed. Then trityl group was removed by TFA and successfully coupled with methyl fumarate by using HATU. All cyclization reactions in the presence of a base like hydroxide, alkoxide or NaH to form morpholinone skeleton was failed. The cyclization reaction with the potassim carbonate in alcohol was successful and the morpholinone skeleton was formed.
  • Master Thesis
    Investigation of Anticancer Properties of Novel Mdm2 Inhibitors
    (Izmir Institute of Technology, 2021) Özdemir, Sefayi Merve; Çağır, Ali
    Cancer is one major disease causing death worldwide. Current cancer treatments are not %100 effective to cure for patients, yet. Thereby, the synthesis and discovery of new therapeutics have been important to improve the survival period of the cancer patients. There are many strategies for synthesis of cancer therapeutics. One of the most important strategy for cancer treatment is the reactivation of p53. MDM2 is a negative regulator of p53 in cell, because it causes the inactivation of p53. In this thesis, the anticancer and MDM2 inhibitory properties of ezetimibe, desfluoro ezetimibe and intermediates during ezetimibe synthesis (named as SM2-9) and a side product from the synthesis of benidipine (named as SM1) on prostate cancer (LnCAP, wild-type p53), breast cancer (MCF7, wild type p53) and uterus cancer (HeLa, wild type nonfunctional p53) cells were investigated. For this purpose, the cytotoxic, cytostatic and apoptotic properties of these compounds were determined. Compounds SM2, SM3, SM4 and SM6 demonstrated cytotoxic effects, whereas compounds SM5, SM8 and SM9 had cytostatic effects on three cells. Compound SM7 had no effect on these cells, up to 100 μM concentration. Compounds SM1 had cytostatic effect on MCF7 cells, but it showed no activity on other cells. Compounds SM8 and SM9 had strong cytostatic activity. Thus, the apoptotic properties of these compounds were examined by caspases 3/7 activation and Annexin-V FITC assays. Besides, MDM2 inhibitor profiles of these compounds were investigated by fluorescence polarization assay. This study provides novel and potential molecules for drug discovery in cancer treatment
  • Master Thesis
    Studies Toward the Asymmetric Synthesis of Ester Functionalized Novel 1,4-Oxazepine Derivatives
    (01. Izmir Institute of Technology, 2021) Bozoğlu, Hülya; Çağır, Ali
    The MDM2/p53 is one of the most widely studied protein-protein interaction because of being a valuable target for the development of novel anticancer agents. MDM2 protein is the natural inhibitor of p53 protein which act as a tumor suppressor. When MDM2 is overexpressed, damaged DNA is allowed to replicate and therefore cancerous cells can be generated because p53 has lost of its activity. For this reason; maintaining the activity of wild-type p53 through inhibition of MDM2 can stop the proliferation of cancer cells. New drugs that inhibit this interaction are important for the treatment of cancer. The aim of the study is synthesize chiral 1,4-oxazepine-5-one derivatives. (R)-2-amino-2-(4-chlorophenyl)acetic acid was used as starting material for the synthesis. The first step was a trityl protection of amine with trityl chloride. Trityl protected amino acid was reduced to N-Trt amino alcohol with LiAlH4 then oxidized to aldehyde by using Dess-Martin periodinane. The resulting aldehyde was reacted with 3-chlorophenylmagnesium bromide. Up to this part of the synthesis, reactions were performed successfully. Then trityl group was removed by TFA and amino alcohol was obtained. Then addition of several α,β-unsaturated carbonyls to the deprotected amino alcohol was studied by coupling reagents such as HATU. Afterwards we performed some intramolecular cyclization attempts but all cyclization attempts were failed.
  • Master Thesis
    Regulation of Human P53 Tumor Suppressor Gene Activity by Thiol-Depentdet Oxidoreductases
    (Izmir Institute of Technology, 2011) Bekki, Gözde; Koç, Ahmet
    Background: Occurrence of p53 mutations in more than half of human tumors indicates the importance of p53 gene in cancer prevention. Nevertheless, oxidation of cysteine-SH groups in p53 protein can inactivate the protein under oxidative conditions. The importance of p53 as a tumor suppressor and insufficient studies about redox regulation of p53 gene lead us to study redox regulation of p53 protein. Methods: In this study, yeast (Saccharomyces cerevisiae) was used as an in vivo model. All potential thiol-dependent antioxidant genes in yeast were identified based on specific characters in their structure, via REDOXCysSearch bioinformatics tool. To study human p53 gene activity in yeast cells, p53 gene and p53 RE Lac-Z reporter that is inducible by p53, were transformed into yeast. Antioxidant gene mutants were analyzed for LacZ reporter gene activity. Results: We identified several yeast mutants (Δsac1, Δhnt3 and Δmap1) with lower p53 activity with respect to wild-type yeast. Conclusion: Due to conserved mechanisms of cell cycle regulation and oxidative stress tolerance between yeast and mammals, we believe that results from yeast studies may help us to understand the redox regulation of p53 in human cells. Thus, a new perspective may appear in the redox regulation of p53 gene.